Data from a cross-sectional population-based study carried out in the town of Bollate (Milan) were used to verify whether there is an age-modulated relationship between the components of blood pressure (BP) and plasma uric acid and fibrinogen levels. Changes in uric acid and fibrinogen levels in relation to diastolic BP (DBP), systolic BP (SBP), mean arterial pressure (MAP) and pulse pressure (PP) in 820 subjects aged 42-59 years and in 509 subjects aged 60-74 years were estimated from general linear models adjusted by the clinical, lifestyle and biological variables traditionally associated with cardiovascular risk. Uric acid levels significantly increased with DBP and MAP only in the middle-aged group without metabolic syndrome or diabetes, and were even in those who were prehypertensive. On the contrary, fibrinogen levels significantly increased with SBP and PP only among the elderly with metabolic syndrome or diabetes, and were particularly high among those with stage 2 hypertension. These findings add evidence concerning an agemodulated relationship between the levels of uric acid and fibrinogen and the steady and pulsatile components of BP and it is possibly related to the different mechanisms underlying increased BP: renal factors in middle-aged subjects and vascular abnormalities in the elderly.
Introduction
Prospective studies have shown a direct and continuous relationship between the level of blood pressure (BP) and the risk of cardiovascular disease throughout middle and old age, 1 with increasing age being associated with a gradual shift in predictive importance from diastolic BP (DBP) to systolic BP (SBP) and finally pulse pressure (PP). 2 Furthermore, BP has been divided into a steady component usually estimated by mean arterial pressure (MAP ¼ (2DBP þ SBP)/3) and a pulsatile component estimated by PP (PP ¼ SBPÀDBP). 3 For a given ventricular ejection fraction and cardiac output, MAP refers to peripheral vascular resistance and PP refers to large artery stiffening: increased resistance and increased stiffness both increase SBP, whereas DBP increases with peripheral resistance and decreases as the large arteries stiffen, and the relative contributions of these opposing forces determine diastolic and, ultimately, PP. Age-related changes in SBP and DBP may therefore reflect the relative contributions of vascular resistance and large artery stiffness to BP patterns in middle-aged and elderly subjects. 4 High BP is a complex condition that is often associated with concomitant disorders such as high plasma levels of uric acid and fibrinogen that may mediate the increase in the risk of cardiovascular disease. 5, 6 Over the last few years, there has been growing interest in the role of uric acid in hypertension, and the results of some studies have highlighted the idea that uric acid may be involved in new-onset early hypertension, but be unrelated to high BP in the elderly. [7] [8] [9] Similarly, the results from previous cross-sectional studies of the association between plasma fibrinogen levels and high BP are conflicting; as reported elsewhere, 10 some have found a positive association, but others have failed to show any independent association between fibrinogen levels and prevalent hypertension, particularly in people aged o65 years. [11] [12] [13] It is not clear whether there is an age-modulated relationship between the components of BP and plasma uric acid and fibrinogen levels, or if this may be related to age differences in the pathogenetic mechanisms underlying hypertension. To gather further insights, we evaluated the relationships between BP components and plasma uric acid and fibrinogen levels in a population of middle-aged and elderly Italians, adjusted by lifestyle, clinical, metabolic and renal function variables.
Methods
We used data from the database of the 1992-93 Italian Bollate Eye Study, 14, 15 which was designed to investigate the prevalence and risk factors of major eye diseases in a random sample of all individuals aged 40-74 years on the residents' list of the town of Bollate (in the province of Milan, Italy). A letter was sent to the sampled subjects to explain the study objectives and invite their participation, after which each was contacted by phone to collect the consent and schedule an appointment at the local hospital outpatient clinic. The project was approved by the National Research Council.
The hospital was attended by 1691 subjects (59% of the original sample), and the visit included an interview regarding their medical and family history, past or current drug use, lifestyle habits, 24-hour dietary recall and a food-frequency questionnaire, and anthropometric (height, weight, body circumferences and skinfolds) and BP measurements (three). A fasting blood sample was collected for laboratory tests (haematology, glycemia, lipids) from 1347 subjects.
Complete lifestyle, clinical and laboratory data were obtained from 1329 subjects. They were classified as non-smokers, ex-smokers or current smokers, and as abstainers or consumers of o30 g per day or 430 g per day alcohol. Education was classified as primary school or less, high school, or further education. Physical activity was assessed on the basis of the time spent watching TV, walking/ cycling and practising sport. Diabetes was defined as plasma glucose levels of 46.94 mmoll À1 and/or oral anti-diabetic use, and subjects were classified as having metabolic syndrome on the basis of the International Diabetes Federation definition. 16 BP was defined as normal, pre-hypertension, or stage 1 or 2 hypertension according to the classification of the National High Blood Pressure Education Program. 17 Glomerular filtration rate (GFR) was estimated using a simplified predictive equation derived from the Modification of Diet in Renal Disease study: 18, 19 General linear models (analysis of covariance) 20 were used to examine the adjusted variations in plasma uric acid and fibrinogen levels in relation to SBP and DBP, and the steady (MAP) and pulsatile (PP) components of BP. Analysis of covariance is a multiple regression model that includes continuous and categorical variables as independent variables.
The estimated variations were adjusted for gender, age, waist circumference, education, smoking, alcohol consumption, physical activity (as evaluated on the basis of practising any sport, walking/cycling and TV watching), triglycerides, high-density lipoprotein cholesterol, glucose, GFR, and the use of non-steroidal anti-inflammatory drugs, diuretics and anti-hypertensive agents. Logarithmic and squared-root transformations of fibrinogen and uric acid were respectively used to reduce the skewness and make the variances homogeneous, and the dependant variables were standardised to make the regression coefficients comparable. The data were analysed separately for the middleaged and the elderly subjects using SPSS 14.0 statistical software (SPSS Inc., Chicago, IL, USA). The cutoff between middle-aged and elderly subjects was chosen at 60 years, as in the recent past, age 460 years was widely considered the cutoff for defining the elderly recipient.
Results
The subjects were 820 individuals aged 42-59 years and 509 aged 60-74 years. Table 1 shows some of their lifestyle, clinical and biological characteristics. Table 2 shows the adjusted linear coefficients measuring the estimated mean variations in plasma uric acid and fibrinogen levels for each 10 mm Hg increase in SBP, DBP, MAP and PP. The analyses were made of the individuals as a whole, and after stratification on the basis of the presence of metabolic syndrome and/or diabetes. As the dependant variables were standardised, the magnitude of the differences is comparable between themselves and as the differences in the adjusted standardised absolute values were too little, per cent values were used to be able to exploit more significant digits using only one decimal place.
Plasma uric acid levels increased significantly with DBP and MAP in the middle-aged subjects, with coefficients (95% confidence interval) of 10.1 (3.3, 16.9) and 7.9 (2.0, 13.8), but not with SBP or PP. In the elderly subjects, none of the BP components correlated with uric acid, but fibrinogen was positively associated with SBP and PP, with coefficients of 7.4 (2.0, 12.8) and 9.7 (3.2, 16.1). There was no association between fibrinogen levels and the BP components in the middle-aged subjects. Furthermore, the increases in uric acid levels associated with DBP and MAP in this group were significant only among those without metabolic syndrome, whereas the increases in fibrinogen levels associated with SBP and PP in the elderly were particularly manifest among those with metabolic syndrome or diabetes.
The relationships between uric acid levels and DBP and MAP in the middle-aged group were examined within the subgroups, with SBPo or X140 mm Hg and PPo or X50 mm Hg; the same was done among the elderly regarding the association of fibrinogen with SBP (the subgroups had DBPo or X90 mm Hg) and PP (the subgroups had MAPo or X106 mm Hg; Table 3 ). In the younger group, the association between uric acid levels and DBP was significant only in the subjects with SBP o140 mmHG, and that between uric acid levels and MAP only among those with PP o50 mm Hg. Similarly, the association between fibrinogen levels and SPB in the elderly was significant only among those with DBP o90 mm Hg, and that between fibrinogen levels and PP only among those with MAP o106 mm Hg. Table 4 shows the adjusted mean differences in plasma uric acid and fibrinogen levels across the BP stages. Using normal BP (SBP o120 and DBP o80 mm Hg) as the reference, uric acid levels increased in the middle-aged subjects with a strong linear trend (P ¼ 0.004) and were significantly higher even in the pre-hypertensive subjects. Among the elderly, fibrinogen levels increased linearly (P-value for linear trend ¼ 0.027), but the difference was significant only for those with stage 2 hypertension (SBP X160 or DBP X100 mm Hg) in comparison with the normal or pre-hypertensive subjects.
Discussion
Substantial differences between the middle-aged and elderly subjects were observed in the relationship between the components of BP and the plasma Uric acid, fibrinogen and blood pressure componentslevels of uric acid and fibrinogen. It is known that different hypertension subtypes have distinct pathophysiological mechanisms and different prognostic implications, 21, 22 and may therefore require different therapeutic approaches. Consequently, a better knowledge of the clinical and laboratory correlates of hypertension subtypes may contribute towards defining and implementing early and specific prevention strategies.
The parameters expressing the relationships of plasma uric acid and fibrinogen levels with the components of BP were estimated after adjusting the models on the basis of the clinical, lifestyle and biological variables traditionally associated with the risk of cardiovascular disease. There was even a term for renal function estimated by the GFR values. Glomerular filtration rate is currently considered the best overall measure of kidney function, but it is susceptible to variations in creatinine methodology.
The values calculated in this study are limited by the lack of standardisation for creatinine measurements that were obtained much before the recent institutional recommendations regarding the calibration against international standards. In spite of this, all measurements were made by the same laboratory and rather than obtaining accurate point estimates of GFR, the aim was to rank individuals on the basis of declining levels of renal function and use it as a control variable. However, any causal inference is precluded by the cross-sectional nature of the study. Our findings regarding plasma uric acid levels are consistent with those of other studies in several ways. Some have found that plasma uric acid levels are positively associated with DBP in adult subjects. 23, 24 The significance of this relationship decreases over time, 25 and it has more recently been found that uric acid levels do not correlate with BP in very elderly patients. 8 In addition, a Taiwanese population-based longitudinal study found that plasma uric acid levels significantly predict incident isolated diastolic hypertension, but not isolated systolic hypertension, 26 and it has also been found that hyperuricemia is common among adults with pre-hypertension. 27 It has recently been suggested that uric acid may have a pathogenic role in hypertension. 28 Longitudinal studies have shown that increased plasma uric acid is associated with an increased risk of future hypertension. 29, 30 In particular, a 6-year follow-up study of men aged 35-57 years without metabolic syndrome showed an 80% excess risk of incident hypertension. 31 The strength of plasma uric acid levels in predicting hypertension is so great that it has been suggested that hyperuricemia may be a mechanism in a unifying pathway for the development of essential hypertension. 32 Plasma uric acid levels have not been found to be associated with an increased risk of incident hypertension only among older men. 9 We found that uric acid levels increased linearly with increasing MAP only in the group of younger subjects. The association was particularly marked in the case of those without metabolic syndrome and therefore probably still affected by uncomplicated alterations in BP. Furthermore, uric acid levels were significantly higher even in the middle-aged subjects with pre-hypertension.
Given the cross-sectional nature of this study, time effects cannot be assessed, but, taken together, the above findings suggest that an increase in uric acid levels may be related to early alterations in BP in the middle-aged subjects. Experimental 33,34 and human 35, 36 studies both provide a possible explanation as to how uric acid might cause hypertension and why this relationship weakens with age. Uric acid induces vascular cell proliferation, inflammation and oxidative stress, and activates the reninangiotensin system; the irreversible damage to small renal vessels leads to salt-sensitive hypertension, which persists regardless of uric acid levels. 37 It would therefore only be associated with new-onset hypertension as long-standing hypertension might already be primarily due to microvascular renal disease. Moreover, when hypertension develops at an older age, other pathophysiological mechanisms specific to the elderly (such as stiffening of the aorta) may become more important. 38 Plasma fibrinogen levels rose with increasing SBP and PP only among the elderly. The positive association between fibrinogenemia and increased PP levels was particularly evident in the subjects with lower levels of MAP, in whom the increase in SBP was probably compensated for by a decrease in DBP, and it has been previously shown that an increase in arterial stiffness accompanied by a decline in DBP is associated with the age-related progression of atherosclerotic disease. 39 Fibrinogen is not only a marker of inflammation, but also determines plasma viscosity. The role of inflammation during atherogenesis has been exten- sively investigated, 40, 41 and there is increasing evidence that acute and low-grade chronic inflammation are associated with the stiffening of large arteries. 42, 43 The mechanism underlying this stiffening is still unclear, but it has been suggested that inflammation may exert its adverse vascular effects by means of structural changes in the artery wall and consequent alterations in arterial elastiticity. 44 It has been found that fibrinogen levels are independently associated with aortic stiffening, thus indicating the important role of fibrinogen as a marker of vascular damage. 45 Plasma viscosity is also high in elderly subjects with isolated systolic hypertension; 46 this further supports the idea that inflammation may participate in mediating the pro-atherosclerotic effects of isolated systolic hypertension, and it has been suggested that increased plasma viscosity could be an easily accessible marker of early atherosclerosis. 46 Unlike the pattern of the uric acid/BP relationship in the younger group, the association between high fibrinogen levels and increased SBP and PP in the elderly was only found in those with metabolic syndrome or diabetes, and the fact that its levels were significantly higher in the subjects with stage 2 hypertension suggests a context of established and probably complicated hypertension. It has been shown that metabolic syndrome is associated with the age-related progression of aortic stiffness, 47 and suggested that inflammation may be the pathophysiological link between metabolic syndrome and arterial stiffness. 48 Arterial stiffness has an important prognostic role because it increases left ventricular afterload and induces left ventricular hypertrophy. 49 High fibrinogen levels have been found to be associated with left ventricular hypertrophy in elderly hypertensive patients 50 and diabetics, 51 and have been suggested as a risk stratification marker. 45 In brief, the results of this study show that the steady and pulsatile components of BP correlate differently with uric acid and fibrinogen levels in middle-aged and elderly subjects, thus extending existing evidence of an age-modulated relationship between BP and both plasma parameters. These differences may be at least partially explained by the fact that uric acid and fibrinogen are differently related to the pathophysiological factors involved in the genesis of high BP; uric acid is related to renal mechanisms, and probably has a primary role in middle-aged subjects, whereas fibrinogen is prevalently related to the structural and functional vascular abnormalities that are more important in inducing hypertension in the elderly. Our findings confirm those of other studies of plasma uric acid, and suggest that conflicting findings of previous studies of the relationship between fibrinogen and BP can probably be because of differences in the study populations. Our finding of a linear relationship between plasma uric acid levels and an isolated increase in DBP in the younger group should also be interpreted in the light of the hypothesis that hyperuricemia may have a role in the initial alterations leading to increased DBP, which suggests the possible usefulness of lowering plasma uric acid levels to prevent hypertension. 52 The finding of a positive linear relationship between fibrinogen levels and PP particularly among elderly subjects with normal MAP values provides a useful warning for clinical practice, as it may indicate the progression of atherosclerotic disease and could perhaps act as a parameter identifying individuals at risk for major cardiovascular complications.
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What is known about this topic K Differences in blood pressure (BP) patterns between middleaged and elderly subjects may reflect the relative importance of the different mechanisms underlying increased BP. K Uric acid may be involved in new-onset early hypertension but may not be correlated with high BP in the elderly; the data regarding an association between fibrinogen levels and high BP are inconsistent.
What this study adds K There is an age-modulated relationship between uric acid and fibrinogen levels and the components of BP; uric acid is associated with high diastolic BP and mean arterial pressure only among middle-aged subjects without metabolic syndrome and/or diabetes, whereas fibrinogen is associated with high systolic BP and pulse pressure only among elderly subjects with metabolic syndrome and/or diabetes. K Increased uric acid levels seem to be related to early alterations in BP measures, and increased fibrinogen levels to those accompanying severe hypertension; the former may be relevant to the prevention of hypertension and the latter to the prevention of its complications.
